Skip to main content
Premium Trial:

Request an Annual Quote

Abbott's MDx Sales Rise 23 Percent in Q2 2010

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Abbott Laboratories today reported 18 percent revenue growth overall for the second quarter ended June 30, and a 23 percent increase in sales of its molecular diagnostic products.

The diagnostics and pharmaceuticals giant reported Q2 sales of $89 million for its molecular diagnostic products, of which $43 million was derived from US sales and the remainder from international markets.

Late in the second quarter, Abbott received US Food and Drug Administration clearance for its molecular diagnostic test for detecting gonorrhea and chlamydia, including a new strain of chlamydia recently discovered in Sweden, and its m2000 molecular diagnostic system.

Abbott said in a statement that it expects to launch more than 12 new molecular diagnostic products over the next two to three years, including several cancer and infectious disease tests, as well as improved instrument systems.

Overall, Abbott reported Q2 revenues of $8.8 billion, up from $7.5 billion for Q2 2010. Its net earnings were flat year over year at $1.29 billion, or $.83 per share.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.